Drug treats 'water intoxication' faster, more effectively
14th Nov 2006, 19:23 GMT
Results of the two largest studies on hyponatremia found that the investigational drug tolvaptan treated hyponatremia -- water intoxication -- more effectively than available treatments. These studies, presented by a researcher from Northwestern University, proved that hyponatremia can be treated with an oral drug that has no significant side effects. Hyponatremia is a relatively common electrolyte disorder. It affects a wide spectrum of patients including those with liver problems, heart failure and the elderly. It also may affect marathon runners.
Drug treats 'water intoxication' faster, more effectively related news:
- Student Says His Drug Test Is Foolproof — AP Top Health News At 8:35 p.m.
- Student says his drug test is foolproof (Associated Press) — Yahoo! Health: Health News
- Paxil Treats 'Compulsive Hoarding' — MedicineNet Daily News
- Changes on tap for water in Manteca. — Environmental Health News
- Main break cuts water supply — The Honolulu Advertiser: Local News
- GE Water to host delegation of 20 Israeli managers — Energy and water |
- Dartco close to final plan for water line in Branchburg. — Environmental Health News
- Global Water Technologies Highlights Growth in Water Industry & Participation in Water Investment Conference — RedOrbit News - Technology
- DEP officials tell Ivy Industrial Park neighbors they may not get answers. — Environmental Health News
- Simple taxi tops this technology — thestar.com: Business Top Stories
Latest news from EurekAlert! - Medicine and Health:
- Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years
- Enbrel first biologic with up to 9 years rheumatoid arthritis safety, sustained efficacy data
- UCSD computer scientist wins Young Investigator Award, research on snake venom proteins highlighted
- Why do insects like to eat some plants more than others?
- Opposites do not attract
- Wild gorillas carriers of an SIV virus close to the AIDS virus
- New data show ACTOS (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT
- Pourquié lab identifies genes involved in formation of vertebral precursors
- Artificial cornea offers better results for infants, some blind patients
- Healthier kids just the click of a remote away